The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021. The vaccine, for which Johnson & Johnson received Emergency Use Authorization from the U.S. Food and Drug Administration in February, is bei...
Any adverse event report about individuals receiving Johnson & Johnson’s single-shot COVID-19 vaccine, as well as our own assessment of the report, is shared with the U.S. Food and Drug Administration, the European Medicines Agency, the World Health Organization and other health authorities ar...
American pharmaceutical giant Johnson and Johnson says its vaccine is very good at preventing people from being hospitalized or dying from COVID-19. The vaccine is the first to use just a single dose and can be stored in a fridge for up to three months, making it a potential game c...
American pharmaceutical giant Johnson and Johnson says its vaccine is very good at preventing people from being hospitalized or dying from COVID-19. The vaccine is the first to use just a single dose and can be stored in a fridge for up to three months, making it a potential gam...
Johnson & Johnson’s one-dose COVID-19 vaccine has been approved for emergency use by the U.S. Food and Drug Administration.
American pharmaceutical giant Johnson and Johnson says its vaccine is very good at preventing people from being hospitalized or dying from COVID-19. The vaccine is the first to use just a single dose and can be stored in a fridge for up to three months, making it a potential...
TheJohnson & JohnsonCOVID-19 single-dose vaccine is compatible with standard vaccine storage and distribution channels with ease of delivery to remote areas. The vaccine is estimated to remain stable for two years at -4°F (-20°C), and a maximum ...
Vaccine demonstrates protection against COVID-19 related hospitalization and death, and across different variants.
Johnson & Johnson (NYSE: JNJ) (the Company) announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between the Janssen Pharmaceutical Companies of Johnson & Johnson and the Bio...
News Release Media contact: Jennifer Dent Jdent1@its.jnj.com Investor Relations: Jennifer McIntyre Office: +1 732 524 3922 Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older Vaccine demonstrates protection against...